These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9801303)

  • 1. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts.
    Scherr M; Rossi JJ
    Nucleic Acids Res; 1998 Nov; 26(22):5079-85. PubMed ID: 9801303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts.
    Scherr M; Rossi JJ; Sczakiel G; Patzel V
    Nucleic Acids Res; 2000 Jul; 28(13):2455-61. PubMed ID: 10871393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.
    't Hoen PA; Out R; Commandeur JN; Vermeulen NP; van Batenburg FH; Manoharan M; van Berkel TJ; Biessen EA; Bijsterbosch MK
    RNA; 2002 Dec; 8(12):1572-83. PubMed ID: 12515389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biophys J; 2002 Jan; 82(1 Pt 1):366-77. PubMed ID: 11751323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.
    Amarzguioui M; Brede G; Babaie E; Grotli M; Sproat B; Prydz H
    Nucleic Acids Res; 2000 Nov; 28(21):4113-24. PubMed ID: 11058107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.
    Sohail M; Hochegger H; Klotzbücher A; Guellec RL; Hunt T; Southern EM
    Nucleic Acids Res; 2001 May; 29(10):2041-51. PubMed ID: 11353073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotide and ribozyme design.
    Probst JC
    Methods; 2000 Nov; 22(3):271-81. PubMed ID: 11071823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of potent antisense oligonucleotides in vitro by semiempirical rules.
    Yanagihara N; Tadakuma H; Ishihama Y; Okabe K; Funatsu T
    J Biosci Bioeng; 2007 Mar; 103(3):270-7. PubMed ID: 17434431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries.
    Ho SP; Bao Y; Lesher T; Malhotra R; Ma LY; Fluharty SJ; Sakai RR
    Nat Biotechnol; 1998 Jan; 16(1):59-63. PubMed ID: 9447595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of mRNA self-structure on hybridization: computational tools for antisense sequence selection.
    Toschi N
    Methods; 2000 Nov; 22(3):261-9. PubMed ID: 11071822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ribonuclease H-oligo DNA conjugate that specifically cleaves hepatitis B viral messenger RNA.
    Walton CM; Wu CH; Wu GY
    Bioconjug Chem; 2001; 12(5):770-5. PubMed ID: 11562195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of RNA secondary structure on cellular antisense activity.
    Vickers TA; Wyatt JR; Freier SM
    Nucleic Acids Res; 2000 Mar; 28(6):1340-7. PubMed ID: 10684928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
    Liang XH; Sun H; Nichols JG; Crooke ST
    Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.
    Gabler A; Krebs S; Seichter D; Förster M
    Nucleic Acids Res; 2003 Aug; 31(15):e79. PubMed ID: 12888531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational selection of antisense oligonucleotide sequences.
    Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
    Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
    Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
    J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.